🔎 Trials Near Me

Dachaigh › Macroglobulinemia Waldenstrom › Colorado

Sgrùdaidhean clionaigeach Macroglobulinemia Waldenstrom ann an Colorado

Tha 8 sgrùdaidhean airson Macroglobulinemia Waldenstrom a’ lorg phàirtichean aig làraichean ann an Colorado.

Bailtean ann an Colorado

Teacsa sgrùdaidh oifigeil (Beurla)

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  • Uchealth North, Fort Collins
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05006716

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

  • Colorado Blood Cancer Institute ( Site 2726), Denver
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT04728893

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • University of Colorado Denver - School of Medicine - Anschutz Medical Campus, Aurora
  • Colorado Blood Cancer Institute, Denver
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07101328

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

  • Colorado Blood Cancer Institute (CBCI), Denver
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06561347

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  • Colorado Blood Cancer Institute, Denver
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Iuch 2026 · NCT05131022

SynKIR-310 for Relapsed/Refractory B-NHL

  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Gibl 2026 · NCT06544265

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

  • Sarah Cannon Research Institute at Colorado Blood Cancer Institute, Denver
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Màrt 2026 · NCT04830137

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

  • Colorado Blood Cancer Institute, Denver
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2025 · NCT05780034

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.